DOCSLIB.ORG

Female Genital System Basic Robbins Chapter 18, Pages 681-704 Big Robbins Chapter 22 M.E

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Female Genital System Basic Robbins Chapter 18, Pages 681-704 Big Robbins Chapter 22 M.E Female Genital System Basic Robbins Chapter 18, pages 681-704 Big Robbins Chapter 22 M.E. Bauman, MD Slides for review: 22, 34, 37, 94, 104, 153, 163, 181, 192, 198, 223 and normal uterus slide. One online clinical case: #12 A woman with vaginal bleeding Note: The material presented below generally follows the outline of Chapter 18 of Basic Robbins. Occasionally the order of the material presented below differs from that of the text; additional material not in the text is also presented. Vulva Labium minus/labia majora Vulvitis Contact irritant dermatitis Contact allergic dermatitis Infectious dermatitis Bartholin gland duct obstruction Non-neoplastic Epithelial Disorders Lichen Sclerosus et atrophicus (figure 18-1) Leukoplakia Lichen simplex chronicus (squamous epithelial hyperplasia) (figure 18-1) Tumors Condyloma (condylomas/condylomata) (figure 18-2) Condylomata lata Condylomata acuminata Vulvar carcinomas Female reproductive page 2 1. HPV16 and 18 associated VIN/VAIN/CIN 2. Non-HPV associated Extramammary Paget disease Vagina Embryology and developmental anomalies Müllerian ducts Mesonephric (wolffian) ducts Arcuate/septate/bicornuate/didelphic uterus Vaginitis Candida albicans Trichomonas vaginalis Gardnerella vaginalis Vaginosis panel Molluscum contagiosum Female reproductive page 3 Malignant neoplasms Squamous cell carcinoma Clear cell carcinoma Vaginal adenosis Sarcoma botryoides (embryonal rhabdomyosarcoma) Cervix Cervicitis Chlamydia trachomatis Neisseria gonorrhea Ureaplasma urealyticum HSV-2 Neoplasia of the cervix Transformation zone (figure 18-4) Risk factors for CIN HPV Vaccines Low risk and high risk HPV (Figure 18-5) Pap tests Female reproductive page 4 CIN/LSIL/HSIL (Figure 18-6, 18-7) Colposcopy/LEEP Cervical carcinoma Body of Uterus (Corpus uteri) Uterus/uteri Endometritis Infection: N. gonorrhea, C. trachomatis, mycobacteria Retained products of conception Intrauterine device Complications Adenomyosis Complications Endometriosis Possible etiologies (figure 18-9) Complications Female reproductive page 5 Histology of the endometrial cycle Menorrhagia Metrorrhagia Oligomenorrhea/Amenorrhea Menopause/postmenopause Abnormal uterine bleeding Female reproductive page 6 AUB secondary to organic uterine lesions AUB secondary to functional etiologies (= dysfunctional uterine bleeding) Proliferative lesions of the endometrium and myometrium Endometrial hyperplasia Endometrial polyps Leiomyoma (leiomyomas, leiomyomata) Leiomyosarcoma STUMP Endometrial carcinoma Type I Type II Female reproductive page 7 Malignant Mixed Müllerian Tumor (Triple MT) Fallopian Tubes Gabriello Fallopio Salpinx Salpingitis Tubo-ovarian abscess Pelvic inflammatory disease (PID) Ovaries Gonadotropic hormones from the hypothalamus cause the anterior lobe of the pituitary gland (pars distalis) to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones stimulate the development of ovarian follicles, which in turn secrete estrogen. Rising estrogen levels trigger a surge of LH. This results in ovulation and the development of the corpus luteum, which begins to secrete progesterone and estrogen. Progesterone builds up the endometrial wall in preparation for implantation (pregnancy). Progesterone also inhibits LH, so if no pregnancy occurs, the corpus luteum causes its own demise. If a pregnancy occurs, the placenta produces human chorionic gonadotropin (hCG) to maintain the corpus luteum and pregnancy. Cochard. Netter's Atlas of Human Embryology: Updated Edition. Saunders, 062012. <vbk:978-1-4557-3977-6#outline(2.3)> Follicular and luteal cysts Corpus luteum/corpora lutea Corpus albicans/corpora albicantia Polycystic ovarian disease (PCOD) Female reproductive page 8 Torsion of ovary Tumors of the ovary 1. 2. 3. 4. 1. Surface epithelial tumors Serous Cystadenoma Mucinous Cystadenofibroma Endometrioid Tumor of low malignant potential Brenner/transitional/urothelial Cystadenocarcinoma Carcinoma Serous tumors Psammoma bodies Low malignant potential Mucinous tumors Pseudomyxoma peritonei Omental “caking” Female reproductive page 9 Endometrioid tumors Brenner/transitional/urothelial tumors 2. Germ cell tumors Teratomas Benign (mature) cystic teratoma/dermoid cyst Malignant (immature) teratoma Specialized teratoma, e.g. struma ovarii Dysgerminomas Yolk sac (endodermal sinus) tumor Schiller-Duval body α-fetoprotein Choriocarcinoma Syncytioblasts and cytotrophoblasts β-hCG 3. Sex cord-stromal tumors Derivation Granulosa cell tumor (granulosa-theca cell tumor) Juvenile granulosa cell tumor Call-Exner bodies Fibroma-thecoma Female reproductive page 10 Meigs syndrome Sertoli-Leydig cell tumor (androblastoma) 4. Metastatic tumors to the ovary Müllerian origin Extra-Müllerian origin Krukenberg tumor Diseases of Pregnancy Placentation Female reproductive page 11 Single umbilical artery Umbilical knot Umbilical cord prolapse Nuchal cord Amniotic band syndrome Placental infarction Placental abruption Placenta accreta/increta/percreta Succenturiate lobe Velamentous insertion of cord Placenta previa Female reproductive page 12 Twin gestations Monozygotic/dizygotic Monoamnionic Monochorionic (MoMo) Diamnionic Monochorionic (DiMo) Diamnionic Dichorionic (DiDi), fused or separate Monochorionic = Twin-twin transfusion syndrome Placental infections Ascending (transcervical) infections PPROM, PROM Chorioamnionitis Funisitis Hematogenous (transplacental) infections T O R C H Ectopic pregnancy Female reproductive page 13 Gestation trophoblastic disease Hydatidiform mole (Table 18-4, Figures 18-19, 18-20) Complete mole Partial mole Invasive mole Choriocarcinoma (Figure 18-21) Gestational Nongestational/Gonadal Preeclampsia/Eclampsia (toxemia of pregnancy) Preeclampsia 1. 2. 3. 3-5% of pregnancies, 3rd trimester, primigravida Eclampsia ≠ gestational hypertension Decreased uteroplacental blood flow Female reproductive page 14 Altered circulating endothelial factors Placenta Maternal endothelial dysfunction End organ failure HELLP in 10% of eclamptic patients H EL LP Rx End of Handout .
Load more

Recommended publications
  • Rare Case Botryoid Rhabdomyosarcomas of the Genital Tract
    ISSN: 2581-5407 DOI: https://dx.doi.org/10.17352/gjct CLINICAL GROUP Received: 25 April, 2020 Case Report Accepted: 29 April, 2020 Published: 30 April, 2020 *Corresponding author: M Lahfaoui, Department Rare Case Botryoid of Pediatric Visceral and Urogenital Surgery, Oujda Children’s Hospital. Morocco, E-mail: Rhabdomyosarcomas of the https://www.peertechz.com Genital Tract. About a case in a 30-month-old child M Lahfaoui* and H Benhaddou Department of Pediatric Visceral and Urogenital Surgery, Oujda Children’s Hospital. Morocco Abstract Rhabdomyosarcomas are the most common soft tissue sarcomas developed in children under 15 years of age. The reported fi nding is a vaginal tumour developed in a 30-month-old granddaughter. This was a typical botryoid rhabdomyosarcoma that usually occurs in the hollow organs lined with mucous membrane. Rhabdomyosarcomas have multiple aspects that vary according to the degree of cellular differentiation. The majority of these tumours can be classifi ed into four histological categories: embryonic, botryoid, alveolar or pleomorphic. Treatment involves excisional surgery combined with radiotherapy and chemotherapy. The prognosis remains bleak despite therapeutic advances in recent years. Introduction Anatomopathological examination of the specimen showed that it was a polypoid (grape-like) tissue bordered Rhabdomyosarcomas are the most common soft tissue by a slightly hyperplastic squamous epithelium. Beneath sarcomas developed in children under 15 years of age. this epithelium, within a myxoid layer, a proliferation of These tumours respond to multidisciplinary management: disseminated tumour cells was observed with an inconspicuous conservative surgery (Figure1), multi-chemotherapy and cytoplasm, a hyperchromatic, rounded or elongated nucleus, radiotherapy. Although the prognosis is always dire, a sometimes presenting cytonuclear atypia with monstrosity signifi cant proportion of children treated in this way do not metastasize [1].
    [Show full text]
  • Differential Diagnosis of Ovarian Mucinous Tumours Sigurd F
    Differential Diagnosis of Ovarian Mucinous Tumours Sigurd F. Lax LKH Graz II Academic Teaching Hospital of the Medical University Graz Pathology Mucinous tumours of the ovary • Primary ➢Seromucinous tumours ➢Mucinous tumours ➢Benign, borderline, malignant • Secondary (metastatic) ➢Metastases (from gastrointestinal tract) • Metastases can mimic primary ovarian tumour Mucinous tumours: General • 2nd largest group after serous tumours • Gastro-intestinal differentiation (goblet cells) • Endocervical type> seromucinous tumours • Majority is unilateral, particularly cystadenomas and borderline tumours • Bilaterality: rule out metastatic origin • Adenoma>carcinoma sequence reflected by a mixture of benign, atypical proliferating and malignant areas within the same tumour Sero-mucinous ovarian tumours • Previous endocervical type of mucinous tumor • Mixture of at least 2 cell types: mostly serous • Association with endometriosis; multifocality • Similarity with endometrioid and serous tumours, also immunophenotype • CK7, ER, WT1 positive; CK20, cdx2 negativ • Most cystadenoma and borderline tumours • Carcinomas rare and difficult to diagnose Shappel et al., 2002; Dube et al., 2005; Vang et al. 2006 Seromucinous Borderline Tumour ER WT1 Seromucinous carcinoma being discontinued? • Poor reproducibility: Low to modest agreement from 39% to 56% for 4 observers • Immunophenotype not unique, overlapped predominantly with endometrioid and to a lesser extent with mucinous and low-grade serous carcinoma • Molecular features overlap mostly with endometrioid
    [Show full text]
  • A Case of Krukenberg Tumor Metastasized from Colon Cancer In
    A case of Krukenberg tumor metastasized from colon cancer in pregnancy Oztas E, Ozler S, Ersoy AO, Turker M, Zengın NI, Caglar AT, Danisman N Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey Objective Krukenberg tumor refers to gastrointestinal cancer metastatic to the ovaries and has an extremely poor prognosis, with a 5-year survival rate ranging from 12% to 23. 4%. Gastric cancer has been reported as the most frequent primary source of Krukenberg tumor; however, tumors of the colon, appendix, breast, lung, and pancreas have also been reported to metastasize into the ovaries. Krukenberg tumors are usually seen in the fifth decade of life, with an average age of 45 years and cases diagnosed during pregnancy are thus extremely rare. Methods We report a case of a Krukenberg tumor secondary to colon carcinoma in a pregnant woman with acute pelvic pain. The prenatal diagnosis was made at 17 weeks’ gestation. Results A 27-year-old, primigravida with a semisolid right adnexial mass was presented with acute pelvic pain at 17 weeks’ gestation. Ultrasonography revealed a semisolid right adnexial mass of 140×130 mm and ascites, as well as a single live fetus compatible for gestational age. The abdomen was tense, tender and distended so exploratory laparotomy was performed with the suspicion of ovarian torsion. During the operation, ascites, enlarged right ovary with the presence of a necrotic tumor measuring 160×140 mm causing ovarian torsion and omental metastasis were seen. Unilateral oophorectomy and omentectomy were then performed. Histopathological examination of the specimen revealed adenocarcinoma metastasis to the ovary and the omentum probably originating from a primary gastrointestinal carcinoma (Figure-1).
    [Show full text]
  • Soft Tissue Sarcoma Classifications
    Soft Tissue Sarcoma Classifications Contents: 1. Introduction 2. Summary of SSCRG’s decisions 3. Issue by issue summary of discussions A: List of codes to be included as Soft Tissue Sarcomas B: Full list of codes discussed with decisions C: Sarcomas of neither bone nor soft tissue D: Classifications by other organisations 1. Introduction We live in an age when it is increasingly important to have ‘key facts’ and ‘headline messages’. The national registry for bone and soft tissue sarcoma want to be able to produce high level factsheets for the general public with statements such as ‘There are 2000 soft tissue sarcomas annually in England’ or ‘Survival for soft tissue sarcomas is (eg) 75%’ It is not possible to write factsheets and data briefings like this, without a shared understanding from the SSCRG about which sarcomas we wish to include in our headline statistics. The registry accepts that soft tissue sarcomas are a very complex and heterogeneous group of cancers which do not easily reduce to headline figures. We will still strive to collect all data from cancer registries about anything that is ‘like a sarcoma’. We will also produce focussed data briefings on sites such as dermatofibrosarcomas and Kaposi’s sarcomas – the aim is not to forget any sites we exclude! The majority of soft tissue sarcomas have proved fairly uncontroversial in discussions with individual members of the SSCRG, but there were 7 particular issues it was necessary to make a group decision on. This paper records the decisions made and the rationale behind these decisions. 2. Summary of SSCRG’s decisions: Include all tumours with morphology codes as listed in Appendix A for any cancer site except C40 and C41 (bone).
    [Show full text]
  • Human Anatomy As Related to Tumor Formation Book Four
    SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section
    [Show full text]
  • Cellular Pseudosarcomatous Fibroepithelial Stromal Polyp of the Cervix: a Lesion Mimicking As Sarcoma
    Advances in Cytology & Pathology Case Report Open Access Cellular pseudosarcomatous fibroepithelial stromal polyp of the cervix: a lesion mimicking as sarcoma Abstract Volume 3 Issue 1 - 2018 Introduction: Fibroepithelial stromal polyps (FESP) are infrequent mesenchymal Mahboob Hasan1 ,Ruquiya Afrose2 ,Mariya lesions found in vulvovaginal region but may also occur in the cervix, usually 1 seen in reproductive age group. FESP exhibiting bizarre cytomorphology, atypical Kamal 1Department of pathology, Aligarh Muslim University, India mitoses, or hypercellularity, raises the possibility of malignancy and continue to be 2Department of pathology, Uttar Pradesh University of Medical underrecognized. Sciences, India Case summary: We report a case of 45 years old, postmenopausal female presented with a large polypoidal cauliflower like growth with ulcerated surface, arising from Correspondence: Ruquiya Afrose, Assistant professor, Department of Pathology, Uttar Pradesh University of Medical exocervix. Cinical diagnosis of cervical malignancy was suggested. Histopathological Sciences, Saifai Etawah, 206301, India, Tel 9219716166, examination revealed a polypoidal tumor mass composed of cellular fibrovascular Email [email protected] stroma covered with stratified squamous epithelium. There are areas showing marked hypercellularity, bizarre cytomorphology and frequent mitotic figures (>10/10 HPF) Received: November 17, 2016 | Published: February 21, 2018 including atypical ones. Important morphologic clues to the diagnosis of FESP were its superficial
    [Show full text]
  • Ovarian Carcinomas, Including Secondary Tumors: Diagnostically Challenging Areas
    Modern Pathology (2005) 18, S99–S111 & 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Ovarian carcinomas, including secondary tumors: diagnostically challenging areas Jaime Prat Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain The differential diagnosis of ovarian carcinomas, including secondary tumors, remains a challenging task. Mucinous carcinomas of the ovary are rare and can be easily confused with metastatic mucinous carcinomas that may present clinically as a primary ovarian tumor. Most of these originate in the gastrointestinal tract and pancreas. International Federation of Gynecology and Obstetrics (FIGO) stage is the single most important prognostic factor, and stage I carcinomas have an excellent prognosis; FIGO stage is largely related to the histologic features of the ovarian tumors. Infiltrative stromal invasion proved to be biologically more aggressive than expansile invasion. Metastatic colon cancer is frequent and often simulates ovarian endometrioid adenocarcinoma. Although immunostains for cytokeratins 7 and 20 can be helpful in the differential diagnosis, they should always be interpreted in the light of all clinical information. Occasionally, endometrioid carcinomas may exhibit a microglandular pattern simulating sex cord-stromal tumors. However, typical endometrioid glands, squamous differentiation, or an adenofibroma component are each present in 75% of these tumors whereas immunostains for calretinin and alpha-inhibin are negative. Endometrioid carcinoma of the ovary is associated in 15–20% of the cases with carcinoma of the endometrium. Most of these tumors have a favorable outcome and they most likely represent independent primary carcinomas arising as a result of a Mu¨ llerian field effect.
    [Show full text]
  • Please Bring Your ~Rotocol, but Do Not Bring Slides Or Microscopes to T He Meeting, CALIFORNIA TUMOR TISSUE REGISTRY
    CALIFORNIA TUMOR TISSUE REGISTRY FIFTY- SEVENTH SEMI-ANNUAL SLIDE S~IINAR ON TIJMORS OF THE F~IALE GENITAL TRACT MODERATOR: RlCl!AlUJ C, KEMPSON, M, D, ASSOCIATE PROFESSOR OF PATHOLOGY & CO-DIRECTOR OF SURGICAL PATHOLOGY STANFORD UNIVERSITY MEDICAL CEllTER STANFOliD, CALIFORNIA CHAl~lAN : ALBERT HIRST, M, D, PROFESSOR OF PATHOLOGY LOMA LINDA UNIVERSITY MEDICAL CENTER L~.A LINDA, CALIPORNIA SUNDAY, APRIL 21, 1974 9 : 00 A. M. - 5:30 P,M, REGISTRATION: 7:30 A. M. PASADENA HILTON HOTEL PASADENA, CALIFORNIA Please bring your ~rotocol, but do not bring slides or microscopes to t he meeting, CALIFORNIA TUMOR TISSUE REGISTRY ~lELDON K, BULLOCK, M, D, (EXECUTIVE DIRECTOR) ROGER TERRY, ~1. Ii, (CO-EXECUTIVE DIRECTOR) ~Irs, June Kinsman Mrs. Coral Angus Miss G, Wilma Cline Mrs, Helen Yoshiyama ~fr s. Cheryl Konno Miss Peggy Higgins Mrs. Hataie Nakamura SPONSORS: l~BER PATHOLOGISTS AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION CALIFORNIA MEDICAL ASSOCIATION LAC-USC MEDICAL CENlllR REGIONAL STUDY GRaJPS: LOS ANGELES SAN F~ICISCO CEt;TRAL VALLEY OAKLAND WEST LOS ANGELES SOUTH BAY SANTA EARBARA SAN DIEGO INLAND (SAN BERNARDINO) OHIO SEATTLE ORANGE STOCKTON ARGENTINA SACRJIMENTO ILLINOIS We acknowledge with thanks the voluntary help given by JOHN TRAGERMAN, M. D., PATHOLOGIST, LAC-USC MEDICAL CENlllR VIVIAN GILDENHORN, ASSOCIATE PATHOLOGIST, I~TERCOMMUNITY HOSPITAL ROBERT M. SILTON, M. D,, ASSISTANT PATHOLOGIST, CITY OF HOPE tiEDICAL CENTER JOHN N, O'DON~LL, H. D,, RESIDENT IN PATHOLOGY, LAC-USC MEDICAL CEN!ER JOHN R. CMIG, H. D., RESIDENT IN PATHOLOGY, LAC-USC MEDICAL CENTER CHAPLES GOLDSMITH, M, D. , RESIDENT IN PATHOLOGY, LAC-USC ~IEDICAL CEUTER HAROLD AMSBAUGH, MEDICAL STUDENT, LAC-USC MEDICAL GgNTER N~IE-: E, G.
    [Show full text]
  • Primary Ovarian Signet Ring Cell Carcinoma: a Rare Case Report
    MOLECULAR AND CLINICAL ONCOLOGY 9: 211-214, 2018 Primary ovarian signet ring cell carcinoma: A rare case report JI HYE KIM1, HEE JEONG CHA1,2, KYU-RAE KIM2,3 and KYUNGBIN KIM1 1Department of Pathology, Ulsan University Hospital, Ulsan 44033; 2Division of Pathology, University of Ulsan, College of Medicine, Seoul 05505; 3Department of Pathology, Asan Medical Center, Seoul 05505, Republic of Korea Received April 18, 2018; Accepted June 12, 2018 DOI: 10.3892/mco.2018.1653 Abstract. Signet ring cell carcinoma (SRCC) of the ovary is and may be challenging. We herein report the case a patient most commonly metastatic from a primary lesion. Primary diagnosed with primary SRCC of the ovary. ovarian SRCC is rare, and the distinction between primary and metastatic SRCC of the ovary may be difficult. We Case report herein present a case of primary SRCC of the ovary in a 54-year-old woman presenting with a right ovarian mass A 54-year-old woman was admitted to the Ulsan University sized 20.5x16.5x11.5 cm. Total abdominal hysterectomy with Hospital (Ulsan, South Korea) with a palpable firm abdominal bilateral salpingo-oophorectomy, partial omentectomy and mass. The patient exhibited no major symptoms and had no incidental appendectomy were performed. Upon histological specific past history. The patient underwent an abdominal examination, mucinous carcinoma composed predominantly computed tomography (CT) scan, which revealed a ~20-cm of signet ring cells was observed in the right ovary. The multiseptated cystic and solid mass arising from the right results of immunohistochemical examination included diffuse ovary. The abdominal CT scan did not reveal any lesions in positivity for cytokeratin (CK)7 and CK20, but the tumor was the gastrointestinal tract.
    [Show full text]
  • A Rare Cause of Painless Haematuria- Adenocarcinoma of Appendix
    Ju ry [ rnal e ul rg d u e S C f h o i l r u a Journal of Surgery r n g r i u e o ] J ISSN: 1584-9341 [Jurnalul de Chirurgie] Case Report Open Access A Rare Cause of Painless Haematuria- Adenocarcinoma of Appendix Shantanu Kumar Sahu1*, Shikhar Agarwal2, Sanjay Agrawal3, Shailendra Raghuvanshi4, Nadia Shirazi5, Saurabh Agrawal1 and Uma Sharma1 1Department of General Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 2Department of Urology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 3Department of Anesthesia, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 4Department of Radiodiagnosis, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 5Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India Abstract Neoplasms of the appendix are rare, accounting for less than 0.5% of all gastrointestinal malignancies and found incidentally in approximately 1% of appendectomy specimen. Carcinoids are the most common appendicular tumors, accounting for approximately 66%, with cystadenocarcinoma accounting for 20% and adenocarcinoma accounting for 10%. Appendiceal adenocarcinomas fall into one of three separate histologic types. The most common mucinous type produces abundant mucin, the less common intestinal or colonic type closely mimics adenocarcinomas found in the colon, and the least common, signet ring cell adenocarcinoma, is quite virulent and associated with a poor prognosis. Adenocarcinoma of appendix is most frequently perforating tumour of gastrointestinal tract due to anatomical peculiarity of appendix which has an extremely thin subserosal and peritoneal coat and the thinnest muscle layer of the whole gastrointestinal tract.
    [Show full text]
  • Pseudomyxoma Peritonei As a Result of Low Grade Appendiceal Mucinous Neoplasm in Association with Ovarian Fibroma
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 13, Issue 1 Ver. X. (Feb. 2014), PP 99-103 www.iosrjournals.org Pseudomyxoma Peritonei As A Result Of Low Grade Appendiceal Mucinous Neoplasm In Association With Ovarian Fibroma. Dr.Deepa.R1 , Dr.R.Sathyalakshmi2 , Dr. Nalli. R . Sumitra Devi3 , Dr. R. Padmavathi4 , Dr.Mary Lilly. S5 Department of Pathology, Stanley Medical College , Chennai , India1. Department of Pathology, Stanley Medical College , Chennai , India2. Department of Pathology, Stanley Medical College , Chennai , India3 Department of Pathology, Stanley Medical College , Chennai , India4. Department of Pathology, Stanley Medical College , Chennai , India5 Abstract: Context : Pseudomyxoma peritonei is a condition caused by the production of abundant mucin by tumor cells which fills the abdominal cavity.(1)The tumor causes fibrosis of tissues and impedes digestion and organ function. If left untreated, tumor and mucin can build up to the point where it compresses vital structures: the colon, the liver, kidneys, stomach, spleen, etc .This disease is most commonly caused by an appendiceal primary tumor. Aims : We describe a case of a 65 year old female with pseudomyxoma peritonei as a result of low grade appendiceal mucinous neoplasm in association with ovarian fibroma . No such cases have been reported in literature till date. Methods and Materials : The patient underwent Left ovariectomy with appendicectomy ,caecal perforation closure and diverting loop ileostomy. Conclusion : Thus we report a rare occurrence of pseudomyxoma peritonei as a result of low grade appendiceal mucinous neoplasm and ovarian fibroma. Key words : Mucinous neoplasm, appendix, ovarian fibroma I.
    [Show full text]
  • Friedrich Krukenberg of Krukenberg's Tumor
    Case report Friedrich Krukenberg of Krukenberg’s Tumor: Report of a series of cases Martin Gómez Zuleta, MD,1 Luis Fernando Benito, MD,2 Cristina Almonacid, MD.3 1 Assistant Professor in the Gastroenterology Unit Abstract of the Department of Internal Medicine at the Universidad Nacional de Colombia and Hospital El Krukenberg’s tumor is an ovarian tumor first described by the German physician Friedrich Krukenberg. It is a Tunal in Bogotá, Colombia metastasis of a primary tumor which is usually located in the stomach. This article presents a brief overview of 2 Third Year Surgery Resident at the Universidad de the history of these tumors and a series of 5 cases which were handled in our service. The aim of this article San Martin in Bogotá, Colombia 3 Pathologist at the Hospital El Tunal and the Clínica de is to demonstrate the complexity of this diagnosis, the therapeutic approach, and the pessimistic prognosis la Policía in Bogotá, Colombia that this condition has. ......................................... Received: 17-01-12 Key words Accepted: 15-05-12 Krukenberg’s tumor, gastric cancer. Friedrich Ernst Krukenberg (1871-1946) was a German of microscopic tubes and glands in Krukenberg tumors. In physician who worked in the city of Marburg under the 1981, Bouillon described in great detail what he called a tutelage of Felix Jacob Marchand, the Chief Medical Officer tubular Krukenberg tumor (3-5). of the Department of Pathology, during his undergraduate The use of the term Krukenberg tumor is based on text- education (1846-1928). Dr. Marchand had had six cases of books published by Scully, Young and Kurman.
    [Show full text]